Company Search:
Advanced Search
Sponsored Links
Immutep Ltd - ADR Company Snapshot
Immutep Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immutep Ltd with three other companies in this sector in the United States: ProQR Therapeutics NV (2019 sales of $2.16 million ), Aclaris Therapeutics Inc ($4.23 million ), and Global Blood Therapeutics Inc ($2.11 million of which 100% was Pharmaceutical).

Sales Analysis. During the year ended June of 2019, sales at Immutep Ltd were $4.31 million. This is a decrease of 20.7% versus 2018, when the company's sales were $5.44 million. Contributing to the drop in overall sales was the 24.0% decline in Cancer Immunotherapy, from $5.30 million to $4.03 million. . However, these declines were partially offset by the increase in sales of Unallocated (up 242.5% to $1.32 million) .
  Stock Performance Chart for Immutep Ltd - ADR
  Stock Data: Recent Stock Performance:
  Current Price (2/21/2020): 2.81
(Figures in U.S. Dollars)
1 Week 5.4%   13 Weeks 41.2%  
4 Weeks 57.9%   52 Weeks 40.5%  
Immutep Ltd - ADR Key Data:
  Ticker: IMMP Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 4,312,912
(Year Ending Jan 2020).
Employees: 19
  Currency: U.S. Dollars Market Cap: 31,957,181
  Fiscal Yr Ends: June Shares Outstanding: 11,372,662
  Share Type: Common Closely Held Shares: 3,089,053
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.